Response to: ‘A dose–response relationship between severity of disc degeneration and intervertebral disc height in the lumbosacral spine’—authors’ reply by unknown
Teichtahl et al. Arthritis Research & Therapy  (2016) 18:45 
DOI 10.1186/s13075-016-0945-xLETTER Open AccessResponse to: ‘A dose–response relationship
between severity of disc degeneration and
intervertebral disc height in the
lumbosacral spine’—authors’ reply
Andrew J. Teichtahl1,2, Donna M. Urquhart1, Yuanyuan Wang1, Anita E. Wluka1, Stephane Heritier1
and Flavia M. Cicuttini1*
See related research by Teichtahl et al., http://www.arthritis-research.com/content/17/1/297 and correspondence
from Emanuel et al., http://dx.doi.org/10.1186/s13075-016-0944-yWe welcome the comments from Emanuel et al. [1].
In a systematic review, Pfirrmann’s method [2] was en-
dorsed as a valid and reliable ‘gold-standard’ for asses-
sing intervertebral disc degeneration [3]. Nevertheless,
the Pfirrmann system uses qualitative descriptors such
as ‘disc height normal to slightly decreased’. This de-
scriptor is highly subjective with confounding influences
of gender, age and body habitus and the ambiguity of
what represents a ‘normal’ disc height. There is no quan-
titative measure of disc height in the Pfirrmann grading
system. This prompted us to validate disc height against
the ‘gold-standard’.
In our work [4], we validate that for every one-grade
increase in the Pfirrmann score, there is a reduction in
disc height. For example, there was a 1.60 mm reduction
(95 % confidence interval –2.37 to –0.83 mm) in disc
height for each Pfirrmann grade increase at the level of
L3/4, independent of age, gender, body mass index and
smoking history. While Emanuel et al. highlight that disc
height has diurnal and joint loading variation [1], the
Pfirrmann Score has the same inherent limitations [2].
Any extraneous variability from such measures would
have served to cause misclassification and reduced our
chances of demonstrating significant results in the
current study. Moreover, contemporaneous assessment
of disc height and the Pfirrmann grade was made, miti-
gating extraneous variability. While there was large* Correspondence: flavia.cicuttini@monash.edu
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probably a reflection of the modest sample size (n = 72)
and is accounted for in regression analyses, with highly
significant results (all p ≤ 0.009).
In our study, we also demonstrated that disc height was
smaller in people with high pain and/or disability, sub-
stantiating the clinical utility of the measure. While
Emanuel et al. argue that factors such as high inter-
subject and intra-subject variation limit the use of disc
height as a clinical or epidemiological measure (e.g. from
diurnal variation in water content of the disc or joint load-
ing), this can be mitigated by standardising assessments to
a particular time of the day (e.g. morning). While quanti-
tative mapping shows promise, such techniques are highly
sophisticated, expensive and not widely available.
We contend that our data validate disc height as a read-
ily available, simple and effective means of assessing inter-
vertebral disc degeneration, but do acknowledge that disc
height may not be the best singular measure for disc de-
generation. We welcome further efforts to identify con-
tinuous measures that sensitively assess disc degeneration.
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